NCT06142825

Brief Summary

The strategy of the CoBAnK study is to establish and enable the function of Community-Facility Transfusion Committees (CFTCs) incorporating diverse representation involving hospital, community, and county leadership, to improve blood availability and transfusion at the point-of-care.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
9

participants targeted

Target at below P25 for not_applicable

Timeline
1mo left

Started Mar 2025

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress93%
Mar 2025Jun 2026

First Submitted

Initial submission to the registry

November 15, 2023

Completed
7 days until next milestone

First Posted

Study publicly available on registry

November 22, 2023

Completed
1.3 years until next milestone

Study Start

First participant enrolled

March 11, 2025

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 11, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 11, 2026

Last Updated

April 9, 2026

Status Verified

April 1, 2026

Enrollment Period

1.3 years

First QC Date

November 15, 2023

Last Update Submit

April 3, 2026

Conditions

Blood Transfusion

Outcome Measures

Primary Outcomes (1)

  • Met blood need

    The proportion of transfusion requests resulting in dispatch of blood products from the laboratory

    The time required for the hospital laboratory to process a request for blood for transfusion, up to two weeks.

Study Arms (2)

CFTC

EXPERIMENTAL

Community-Facility Transfusion Committees (CFTCs) will be established at the facilities randomized to this arm.

Other: Community-Facility Transfusion Committee (CFTC)

Control

NO INTERVENTION

Interventions

Community-Facility Transfusion Committee (CFTC)OTHER

Community-Facility Transfusion Committees (CFTCs) are intended to incorporate diverse representation involving hospital, community, and county leadership, to improve blood availability and transfusion at the point-of-care.

CFTC

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Eligibility criteria for study sites (beta hospitals): * Transfusing hospital at level 3 or higher * Has conducted at least 20 blood transfusions in the preceding year * Does not have a KTTA-approved blood bank (regional or satellite) in the facility premises * Receives blood from a blood bank at an Alpha Facility in the same county

Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.

Sponsors & Collaborators

Study Sites (1)

University of Minnesota

Minneapolis, Minnesota, 55414, United States

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Model Details: Type III hybrid effectiveness-implementation trial
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 15, 2023

First Posted

November 22, 2023

Study Start

March 11, 2025

Primary Completion (Estimated)

June 11, 2026

Study Completion (Estimated)

June 11, 2026

Last Updated

April 9, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

The BLOODSAFE project is committed to quickly sharing results and data. Papers will be submitted summarizing the primary results of the BLOODSAFE studies once the analysis is complete. These results will be published in major scientific journals and presented at scientific meetings.

Locations

US(1)